Literature DB >> 33704617

RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients.

Xiao-Min Li1, Hong-Lin Chen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33704617     DOI： 10.1007/s10549-021-06146-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  4 in total

1.  Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.

Authors:  Marianna Cavazza; Helen Banks; Michele Ercolanoni; Gjiliola Cukaj; Giulia Bianchi; Giuseppe Capri; Francesco Longo
Journal:  Breast Cancer Res Treat       Date:  2020-06-26       Impact factor: 4.872

2.  Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients.

Authors:  Miryam Yusufov; Margo Nathan; Aleta Wiley; Julia Russell; Ann Partridge; Hadine Joffe
Journal:  Breast Cancer Res Treat       Date:  2020-09-12       Impact factor: 4.872

3.  Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide.

Authors:  Wing Chow; Prina Donga; Aurélie Côté-Sergent; Carmine Rossi; Patrick Lefebvre; Marie-Hélène Lafeuille; Hélène Hardy; Bruno Emond
Journal:  Patient Prefer Adherence       Date:  2020-11-23       Impact factor: 2.711

4.  Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross-sectional survey.

Authors:  Hui Xu; Feng Jin; Xiu-Jie Zhang; Da-Qiu Wang; Shao-Fen Yu; Ai-Ping Wang
Journal:  Cancer Med       Date:  2020-04-01       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.